Cervical cancer

2022-RA-1217-ESGO Succor Morbidity. Intraoperative and postoperative complications inminimally invasive versus open radical hysterectomy in early cervical cancer

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.100 Daniel Vázquez Vicente, F. Boria, T. Castellanos, M. Gutiérrez, E. Chacón, N. Manzour, J. Minguez, J. Alcázar, L. Chiva

2022-RA-426-ESGO Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical impact in patients with cervical cancer: subgroup analysis of the SCCAN project

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.22 L. Dostálek, K. Benešová, J. Klat, Sarah H. Kim, H. Falconer, J. Kosťun, dos Reis Ricardo, I. Zapardiel, David Isla Ortiz, L. V. van Lonkhuijzen, A. Lopez, D. Odetto, M. Borčinová, J. Jarkovský, S. Salehi, K. Němejcová, P. Dundr, K. Park, V. Javůrková, N. Abu-Rustum, D. Cibula

2022-RA-579-ESGO A phase II study assessing safety and efficacy of cabozantinib for advanced or metastatic cervical carcinoma after platinum treatment failure (CABOCOL study)

Pub Date : 2022-10-01 DOI: 10.1136/ijgc-2022-esgo.30 E. Coquan, J. Lequesne, E. Colomba, J. Frenel, C. Abdeddaim, V. D'Hondt, M. Castera, S. Abadie-Lacourtoisie, C. Dubot, P. Brachet, A. Leconte, B. Clarisse, Florence Joly